Current Issue 21 May 2012, Vol. 586, No. 10

Issue Highlights

Focus on... Ubiquitin-Related Tumor Suppressors

  • Pirh2 RING-finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
    21 May 2012(Vol. 586 | No. 10 | Pages 1397-1402)

    Yong-Sam Jung, Yingjuan Qian, Xinbin Chen

  • Merlin, a multi-suppressor from cell membrane to the nucleus
    21 May 2012(Vol. 586 | No. 10 | Pages 1403-1408)

    Lu Zhou, C. Oliver Hanemann

  • PHD finger of the SUMO ligase Siz/PIAS family in rice reveals specific binding for methylated histone H3 at lysine 4 and arginine 2
    22 May 2012

    Heisaburo Shindo, Rintaro Suzuki, Wataru Tsuchiya, Misako Taichi, Yuji Nishiuchi, Toshimasa Yamazaki

  • The human phosphatase interactome: an intricate family portrait
    22 May 2012

    Francesca Sacco, Livia Perfetto, Luisa Castagnoli, Gianni Cesareni

  • Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling
    21 May 2012

    Leszek Kotula

  • Redesigning the single-chain variant of the restriction endonuclease PvuII by circular permutation
    21 May 2012

    Benno Schierling, Wolfgang Wende, Alfred Pingoud

  • A plant microRNA regulates the adaptation of roots to drought stress
    21 May 2012

    Hao Chen, Zhuofu Li, Liming Xiong

  • View More Articles in Press...



On the Cover


Cover Image

More About FEBS

FEBS, since its inception in 1964, has promoted life sciences and supported scientists in Europe and elsewhere, and is one of the largest not-for-profit organizations in life sciences today. Among the offers to our members are participation in advance courses, the support of fellowships and participation in our annual Congress. All activities related to FEBS are financed by income generated by our four publications: FEBS Letters, FEBS Journal, Molecular Oncology, and FEBS OpenBio. As reader or author of papers in these journals, you contribute to our mission: To foster scientific excellence and promote science for society. Thank you for your support. For more information on FEBS, please visit www.febs.org.

Publishing Information

FEBS Letters is published by Elsevier BV on behalf of the Federation of European Biochemical Societies.



Access this journal onSciVerse ScienceDirect
Print or Share This Page

Announcements

FEBS Letters Structured Digital Abstracts Experiment

Protein interaction papers to have Structured Digital Summary

Read the Press Release for more details and explanation of this innovative experiment.

Past Announcements

Special Issues

      

Virtual Special Issues

FEBS Letters is proud to launch a new series of Virtual Special Issues which will highlight a collection of outstanding articles recently published in the journal, focusing on a selection of topics that we hope will be of general interest to our readers.